(Q37924497)

25 August 2017

1 reference

title

Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care (English)

1 reference

25 August 2017

main subject

venous thromboembolism

1 reference

Scott Kaatz

1

1 reference

25 August 2017

Alex C Spyropoulos

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

39

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

7-15

1 reference

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Health care delivery system reform: accountable care organizations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Transitions of Care Consensus Policy Statement American College of Physicians-Society of General Internal Medicine-Society of Hospital Medicine-American Geriatrics Society-American College of Emergency Physicians-Society of Academic Emergency Medici

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Lack of thromboprophylaxis across the care continuum in US medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Need to improve thromboprophylaxis across the continuum of care for surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Development and validation of a predictive model for chemotherapy-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Practice parameters for the prevention of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Venous thromboembolism in the outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2011.08.574

21 January 2018

Identifiers

DOI

10.3810/HP.2011.08.574

1 reference

25 August 2017

1 reference